Related Tags >> FDA Humira AstraZeneca pharmaceuticals

Abbott Labs News

Most Popular Abbott Labs Story

Dry antibiotic pipeline concerns infectious disease experts

November 5, 2007 — 7:59am ET

The Infectious Diseases Society of America has been beating the drum over a paucity of new antibiotic approvals. With drug developers lured by bigger margins in other disease categories, drug... Read more...

Abbott Labs Press Releases

PRESS RELEASE: Abbott to Present Comprehensive Safety and Efficacy Data on XIENCE
PRESS RELEASE: Abbott Confirms FDA Advisory Panel to Review XIENCE™ V Drug Eluting Stent on November 29
PRESS RELEASE: Abbott and Solvay Pharmaceuticals to co-promote Abbott's Simcor in the United States
PRESS RELEASE: New Prescription Allergy Treatment XYZAL Now Available for Fall Allergy Season

Latest Headlines

Abbott opens R&D facility, invests $53M
June 13, 2008
ALSO NOTED: ASCO news; Acorda shares surge on data; Genentech, Exelixis and Celgene win kudos; and much more...
June 2, 2008
ALSO NOTED: Arqule hires new CEO; Kosan launches mid-stage study; and much more...
April 15, 2008
SPOTLIGHT: Takeda buying out TAP partner
March 19, 2008
ALSO NOTED: Genta inks licensing deal on oncology program; Abbott, et al, target Tarceva gene test; Gilead submits marketing ap
March 7, 2008
Mystery suitor spurs spike in CeNeS stock
February 5, 2008
ALSO NOTED: Houston develop plots biotech park; Galvus wins EU nod; OncoMethylome inks deal with Abbott; and much more...
December 17, 2007
ALSO NOTED: GPC Biotech's CFO resigns; Abbott Labs cuts 1,200 jobs; and much more...
December 5, 2007
Dry antibiotic pipeline concerns infectious disease experts
November 5, 2007
ALSO NOTED: Enzon sells drug interest; Generex gains new patents; Access plans trials;and much more...
August 20, 2007
GE, Abbott call off $8.1B diagnostics deal
July 13, 2007
Press Release: Abbott Laboratories and Genentech to Co-Develop Two Cancer Drugs
June 26, 2007
SPOTLIGHT: Abbott teams with Genentech
June 26, 2007
Press Release: General Electric To Acquire Abbott Laboratories's In Vitro And Point-Of-Care Diagnostics Businesses For $8.13B
January 19, 2007
Abbott deal puts focus squarely on pharma
January 18, 2007
GE negotiating for Abbott diagnostics unit
January 17, 2007
SPOTLIGHT: FDA expands Humira approval
November 13, 2006
DEALS: Abbott buys Kos in $3.7B deal
November 8, 2006
Abbott to buy Kos for $3.7B
November 5, 2006
SPOTLIGHT: FDA to give Humira priority review for Crohn's
October 26, 2006

Paid Research Reports